Loading...

Home
ETF
ACHV

ACHV

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ACHV News

Achieve Life Sciences Appoints Mark Rubinstein as Chief Medical Officer

Jan 12 2026NASDAQ.COM

Achieve Life Sciences Submits NDA for Cytisinicline, Expected U.S. Launch in 2026

Dec 30 2025Benzinga

Achieve Life Sciences to Host Investor Meetings at 2026 J.P. Morgan Healthcare Conference

Dec 17 2025PRnewswire

Achieve Life Sciences Grants 250,000 Stock Options to New Chief Legal Officer

Dec 08 2025Globenewswire

Citizens Begins Coverage of Achieve Life Sciences (ACHV) with a Positive Market Outlook

Nov 26 2025NASDAQ.COM

Citizens Begins Coverage of Achieve Life Sciences with Market Outperform Rating and Sets Price Target at $19

Nov 25 2025Benzinga

Achieve Life Sciences Awarded FDA Commissioner’s National Priority Voucher for Cytisinicline to Aid in E-cigarette and Vaping Addiction Treatment

Oct 17 2025Newsfilter

Achieve, Disc, and Revolution Among Recipients of First FDA National Priority Vouchers

Oct 17 2025SeekingAlpha

Achieve Life Sciences Publishes Data in Thorax Highlighting Cytisinicline's Potential Effectiveness and Tolerability for Smoking Cessation in COPD Patients

Sep 22 2025Newsfilter

Achieve Life Sciences Elevates Craig Donnelly to Chief Operations Officer

Sep 18 2025Newsfilter

Achieve Life Sciences Appoints New Interim Chief Medical Officer

Sep 12 2025SeekingAlpha

Achieve Life Sciences Appoints Interim Chief Medical Officer

Sep 11 2025Yahoo Finance

FDA Evaluating Achieve Life Sciences' Treatment for Nicotine Dependence

Sep 03 2025SeekingAlpha

Achieve Life Sciences Moves Closer to FDA Approval for First New Smoking Cessation Drug in Two Decades

Aug 21 2025Benzinga

Achieve (ACHV) Q2 Net Loss Hits $12.7M

Aug 07 2025NASDAQ.COM

Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program

Aug 07 2025Newsfilter